Inflammation is driven by a coordinated cast of immune cells, each playing a distinct role at different stages. The earliest responders are neutrophils and mast cells, which arrive within seconds to minutes of tissue damage or infection. But the full picture includes macrophages, T cells, and even non-immune cells like fibroblasts that can keep inflammation going long after the initial threat is gone.
Mast Cells: The First Alarm
Mast cells are stationed throughout your tissues, positioned like sentinels waiting for trouble. When they detect an allergen, pathogen, or tissue damage, they release preformed packets of chemicals within seconds. The most well-known of these is histamine, which widens blood vessels and makes them leaky. That leakiness is what causes the redness, warmth, and swelling you associate with inflammation. Mast cells also release tumor necrosis factor alpha (a powerful inflammatory signaling molecule), along with proteases that break down surrounding tissue to help immune cells access the area.
Histamine works through receptors on nearby cells to trigger a rapid chain of effects: smooth muscle contraction in the airways, increased mucus production, a faster heart rate, and flushing of the skin. This is why allergic reactions, which are essentially mast cells overreacting, produce such a dramatic and fast response.
Neutrophils: The Rapid Strike Force
Neutrophils are the most abundant white blood cells in your bloodstream and among the first to arrive at a site of infection or injury. They work by engulfing bacteria and foreign material, then destroying it with enzymes stored in internal granules. They also release fibers into surrounding tissue that trap bacteria, preventing them from spreading.
Getting neutrophils to the right place involves a precise multi-step process. When tissue is damaged, the cells lining nearby blood vessels change their surface, displaying sticky adhesion molecules that grab passing neutrophils. The neutrophils then roll along the vessel wall, firmly attach, crawl to a gap between cells, and squeeze through into the tissue. Chemical gradients produced by damaged cells and bacteria guide neutrophils toward the exact spot where they’re needed. Prostaglandins, the same compounds that pain relievers like ibuprofen block, are among the signals that help neutrophils cross the vessel wall.
Basophils and Eosinophils
Basophils circulate in the blood and function similarly to mast cells. When they encounter allergens, they release histamine and chemical signals that recruit neutrophils and eosinophils to the area. Eosinophils produce their own set of inflammatory substances and are particularly active during allergic reactions and parasitic infections. Together with mast cells, these three cell types form the core of allergy-driven inflammation.
Macrophages: Drivers of Chronic Inflammation
If neutrophils are the rapid strike force, macrophages are the occupying army. These large immune cells take up residence in tissues and can persist for weeks or months. What makes them especially important is their ability to shift between two very different states.
In their pro-inflammatory state, macrophages generate reactive oxygen species, toxic molecules that kill pathogens but also damage surrounding tissue. These macrophages have strong antibacterial and anticancer activity, but when they remain active too long, they hinder wound healing and tissue regeneration. This is a central mechanism in chronic inflammation: macrophages that stay locked in their aggressive mode keep producing tissue damage even after the original infection is cleared.
In their anti-inflammatory state, macrophages do the opposite. They clean up dead cells and debris, suppress inflammation, promote wound healing, and stimulate new blood vessel growth. The balance between these two states determines whether inflammation resolves normally or becomes a chronic, destructive process. Signals from other immune cells tip macrophages one way or the other. Certain inflammatory proteins push them toward aggression, while others steer them toward repair.
How Blood Vessel Cells Enable the Process
The cells lining your blood vessels, called endothelial cells, aren’t immune cells, but they play a critical gatekeeper role. Normally, endothelial cells form a tight barrier that keeps immune cells inside blood vessels. During inflammation, signaling molecules like TNF-alpha and IL-6 activate endothelial cells, causing them to display adhesion molecules on their surface. These act like Velcro, catching immune cells as they flow past and directing them into the inflamed tissue.
Healthy endothelial cells produce nitric oxide, which actively suppresses this activation. When nitric oxide production drops, adhesion molecules appear and immune cells begin sticking to vessel walls, even without an obvious injury. This is one reason why conditions that damage blood vessels, like high blood pressure or diabetes, are associated with chronic low-grade inflammation.
Dendritic Cells: Connecting Quick and Lasting Responses
Dendritic cells serve as a bridge between the body’s immediate inflammatory reaction and the slower, more targeted adaptive immune response. They patrol tissues in an immature state, picking up fragments of pathogens and damaged cells. Once they capture enough material, they mature and migrate to lymph nodes, where they present these fragments to T cells. This is the critical step that activates the adaptive immune system, turning a general alarm into a targeted attack.
Without dendritic cells, T cells would rarely encounter the information they need to respond. Dendritic cells are the only immune cells that can efficiently activate T cells that have never seen a particular threat before, making them essential for mounting a full immune response to new infections.
T Cells and Autoimmune Inflammation
Once activated by dendritic cells, certain T cells become powerful drivers of inflammation on their own. One subset, called Th17 cells (identified in 2006), is particularly relevant. These cells secrete a signaling molecule called IL-17 that ramps up inflammation and recruits more immune cells to the site. Th17 cells are essential for fighting off bacteria and fungi that invade through the skin or gut lining.
The problem arises when Th17 cells target the body’s own tissues. Research in both animal models and human studies has shown that Th17 cells play a key role in autoimmune diseases like rheumatoid arthritis, psoriasis, and inflammatory bowel disease. In these conditions, the immune system generates a self-sustaining inflammatory loop: dendritic cells activate Th17 cells, which recruit more immune cells, which cause tissue damage, which activates more dendritic cells.
Fibroblasts: When Structural Cells Fuel Inflammation
Not all cells that drive inflammation are immune cells. Fibroblasts, the structural cells that maintain connective tissue throughout your body, can become activated during chronic inflammation and take on an aggressive role. Activated fibroblasts, called myofibroblasts, worsen inflammatory disease by co-opting their normal tissue-maintenance functions. Instead of simply producing the scaffolding that holds tissues together, they begin recruiting immune cells and reshaping the tissue environment in ways that sustain inflammation.
In cancer, activated fibroblasts create a cellular niche at the edges of tumors that supports immune suppression, helping tumors evade the immune system. They do this partly by attracting regulatory T cells through specific chemical signaling pathways. This makes fibroblasts a growing focus of research in both chronic inflammatory diseases and cancer biology.
Inflammatory Markers Your Doctor Measures
The collective activity of all these cells produces measurable signals in the blood. C-reactive protein (CRP) is the most commonly tested. Clinically, a CRP level of 1 mg/L or below is considered low risk, 1 to 10 mg/L suggests moderate inflammation, and above 10 mg/L indicates significant inflammation that could reflect infection, autoimmune flare, or other serious conditions. IL-6 and TNF-alpha are two other markers that reflect the intensity of the inflammatory response, though they’re tested less routinely.
These markers don’t point to a single cell type. They represent the combined output of macrophages, mast cells, T cells, and endothelial cells all signaling at once. That’s why elevated CRP on its own doesn’t tell you what’s wrong, only that your immune system is actively responding to something.